These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28622476)

  • 21. Transdermal hormone replacement therapy with nanostructured medicines.
    Abdi F; Darooneh T; Ghorbani M; Banihashemi F; Roozbeh N
    Ginekol Pol; 2017; 88(2):103-108. PubMed ID: 28326520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multicenter, open-label study to evaluate satisfaction and menopausal quality of life in women using transdermal estradiol/norethindrone acetate therapy for the management of menopausal signs and symptoms.
    Adler G; Young D; Galant R; Quinn L; Witchger MS; Maki KC
    Gynecol Obstet Invest; 2005; 59(4):212-9. PubMed ID: 15753617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of progestin-only treatment for the management of menopausal symptoms: a systematic review.
    Dolitsky SN; Cordeiro Mitchell CN; Stadler SS; Segars JH
    Menopause; 2020 Nov; 28(2):217-224. PubMed ID: 33109992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vasomotor hot flushes and 24-hour ambulatory blood pressure in normotensive women: A placebo-controlled trial on post-menopausal hormone therapy.
    Tuomikoski P; Haapalahti P; Sarna S; Ylikorkala O; Mikkola TS
    Ann Med; 2010 Jul; 42(5):334-43. PubMed ID: 20429800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women.
    Simon J; Klaiber E; Wiita B; Bowen A; Yang HM
    Menopause; 1999; 6(2):138-46. PubMed ID: 10374221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulsed estrogen therapy: relieving climacteric symptoms, preventing postmenopausal bone loss.
    Palacios S
    Climacteric; 2002 Jun; 5 Suppl 2():32-9. PubMed ID: 12482109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years.
    Diem S; Grady D; Quan J; Vittinghoff E; Wallace R; Hanes V; Ensrud K
    Menopause; 2006; 13(1):130-8. PubMed ID: 16607109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-dose transdermal estradiol for vasomotor symptoms: a systematic review.
    Corbelli J; Shaikh N; Wessel C; Hess R
    Menopause; 2015 Jan; 22(1):114-21. PubMed ID: 24977458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of hormone replacement therapy and tibolone on lipoprotein (a) concentrations in postmenopausal women: A systematic review and meta-analysis.
    Anagnostis P; Galanis P; Chatzistergiou V; Stevenson JC; Godsland IF; Lambrinoudaki I; Theodorou M; Goulis DG
    Maturitas; 2017 May; 99():27-36. PubMed ID: 28364865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormone replacement therapy in postmenopausal women.
    Yasui T; Uemura H; Takikawa M; Irahara M
    J Med Invest; 2003 Aug; 50(3-4):136-45. PubMed ID: 13678382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of steady state development and reduction of menopausal symptoms after oral or transdermal delivery of 17-β-estradiol in young healthy symptomatic menopausal women.
    Rohr UD; Volko CD; Schindler AE
    Horm Mol Biol Clin Investig; 2014 Jun; 18(3):123-36. PubMed ID: 25390008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of efficacy and local tolerability of estradiol metered-dose transdermal spray to estradiol patch in a network meta-analysis.
    Kovács G; Zelei T; Vokó Z
    Climacteric; 2016 Oct; 19(5):488-95. PubMed ID: 27593417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of the effects of oral and transdermal estrogen replacement on insulin sensitivity in postmenopausal women.
    O'Sullivan AJ; Ho KK
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1783-8. PubMed ID: 7775623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on hormone therapy for the management of postmenopausal women.
    Pan M; Pan X; Zhou J; Wang J; Qi Q; Wang L
    Biosci Trends; 2022 Mar; 16(1):46-57. PubMed ID: 35013031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Basic principles of hormone replacement therapy in the postmenopause].
    Dören M
    Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hot flushes and biochemical markers for cardiovascular disease: a randomized trial on hormone therapy.
    Tuomikoski P; Mikkola TS; Tikkanen MJ; Ylikorkala O
    Climacteric; 2010 Oct; 13(5):457-66. PubMed ID: 20443719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of menopausal hormonal therapy on cardiovascular risks in Korean postmenopausal women: A nationwide cohort study.
    Yuk JS; Kim GS; Byun YS; Yang SW; Kim MH; Yoon SH; Seo YS; Kim BG
    BJOG; 2024 Aug; 131(9):1306-1317. PubMed ID: 38465460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The menopausal transition: how does route of delivery affect the risk/benefit ratio of hormone therapy?
    Shulman LP
    J Fam Pract; 2004 Jul; Suppl():S13-7. PubMed ID: 15251108
    [No Abstract]   [Full Text] [Related]  

  • 40. Transdermal estrogen in the treatment of hot flushes in men with prostate cancer.
    Gerber GS; Zagaja GP; Ray PS; Rukstalis DB
    Urology; 2000 Jan; 55(1):97-101. PubMed ID: 10654902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.